A North East firm is set to commercialise its non-invasive drug test on the back of a £600,000 investment.
Durham-based Applied Monitoring has developed technology that can detect alcohol and drugs in a person’s blood by scanning their skin – tech that is much quicker and cheaper than current onsite workplace tests.
The firm is now looking to commercialise its product on the back of a funding round co-led by the North East Venture Fund (NEVF), supported by the European Regional Development Fund and managed by Mercia, and the Finance Durham Fund, managed by Maven Capital Partners, established by Durham County Council and overseen by Business Durham.